Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) saw unusually-strong trading volume on Wednesday . Approximately 80,682 shares were traded during mid-day trading, an increase of 208% from the previous session’s volume of 26,167 shares.The stock last traded at $153.23 and had previously closed at $155.23.
First Trust NYSE Arca Biotechnology Index Fund Stock Down 0.1 %
The company has a market capitalization of $997.17 million, a price-to-earnings ratio of 22.54 and a beta of 0.70. The stock has a 50 day simple moving average of $166.78 and a 200 day simple moving average of $170.33.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Raymond James Financial Inc. acquired a new stake in First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter worth about $27,765,000. GAMMA Investing LLC lifted its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 60,456.6% in the 1st quarter. GAMMA Investing LLC now owns 96,285 shares of the company’s stock worth $16,380,000 after acquiring an additional 96,126 shares during the period. Modern Wealth Management LLC bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter valued at approximately $5,216,000. Garden State Investment Advisory Services LLC acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the third quarter valued at approximately $4,494,000. Finally, Jane Street Group LLC bought a new stake in First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter worth approximately $3,247,000.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Read More
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- Manufacturing Stocks Investing
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- What Are Dividend Contenders? Investing in Dividend Contenders
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- What is the Shanghai Stock Exchange Composite Index?
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
